首页 > 市场调查报告书 > 製药

北美色素沉着过度障碍治疗市场预测至 2030 年 - 区域分析 - 按治疗类型、病情和最终用户

市场调查报告书

商品编码

1597094

北美色素沉着过度障碍治疗市场预测至 2030 年 - 区域分析 - 按治疗类型、病情和最终用户

North America Hyperpigmentation Disorder Treatment Market Forecast to 2030 - Regional Analysis - by Treatment Type, Condition, and End User

出版日期: 2024年10月03日 | 出版商:

The Insight Partners | 英文 84 Pages | 订单完成后即时交付

价格

简介目录图表

2022年北美色素沉着过度障碍治疗市场估值为16.9483亿美元，预计2030年将达到30.2873亿美元；预计2022年至2030年复合年增长率为7.5%。

黄褐斑盛行率的上升推动了北美色素沉着过度疾病治疗市场

黄褐斑是最主要的色素沉着过度病症之一，其特征是对称的浅色至深色泥褐色斑疹，边界位于脸部，特别是下巴、上唇、鼻子、前额和脸颊。它在女性和肤色较深的人中普遍存在。颧骨、下颚和脸部中央的临床特征在黄褐斑中很常见。阳光照射、荷尔蒙变化、怀孕、遗传因素、化妆品和药物都与黄褐斑的发生有关。各种研究估计，一般人群中黄褐斑的总体盛行率在 1% 到 50% 之间。 55-64% 的黄褐斑病例报告有相同病症的家族史。此外，据报道，东亚和西班牙裔以及具有高 Fitzpatrick 皮肤光型（IV 至 VI）的患者的盛行率更高；居住在受到强烈紫外线辐射的地方的人的这一比例也更高。

怀孕是黄褐斑的另一个常见原因。这种情况也会影响服用口服避孕药和荷尔蒙的女性。雌激素、黄体素和黑色素细胞刺激激素水平通常在怀孕晚期升高，这可能是一个因素。根据美国国家生物技术资讯中心（NCBI）2023年8月的数据，黄褐斑在育龄期更为常见，青春期之前很少发生； 15-50%的孕妇会出现这种情况，盛行率从1.5%到33%不等，取决于不同地区的人口。因此，黄褐斑盛行率的激增引发了对色素沉着过度治疗的需求。

北美色素沉着过度疾病治疗市场概述

北美色素沉着过度症治疗市场分为美国、加拿大和墨西哥。 2023 年，美国占据北美最大的色素沉着过度障碍治疗市场份额。该国的亚洲人口和非洲人，这也可能导致2050 年左右，少数族群转向菲茨帕特里克III、IV、V 和VI 皮肤类型。具体而言，西班牙裔人口预计将成为美国成长最快的人口群体之一，预计将从 2014 年的 5,500 万人增长到 2060 年的 1.19 亿。

过去 10 年来，美国的美容手术数量显着增加。根据国际整形外科医师协会 (ISAPS) 的数据，与 2020 年相比，2021 年全球非手术美容手术数量增加了 19.9%。强烈脉衝光(IPL) 治疗是前5 名的微创美容手术之一，2020 年美国进行了约827,000 例IPL 手术。市场。 2023 年 3 月，美国食品药物管理局 (FDA) 批准 Candela Corporation 的 PicoWay 雷射治疗牛奶咖啡、黄褐斑、雀斑和太田痣。此前，该雷射系统已被批准用于治疗良性色素病变、痤疮疤痕、皱纹和去除纹身等适应症。

因此，民族和种族多样性的不断增长，以及药妆、化学换肤、冷冻疗法、光或雷射疗法等非侵入性医疗美容手术的发展等因素促进了美国色素沉着过度疾病治疗市场的成长。

北美色素沉着过度疾病治疗市场收入及 2030 年预测（百万美元）

北美色素沉着过度疾病治疗市场细分

北美色素沉着过度障碍治疗市场按治疗类型、病情、最终用户和国家分类。

根据治疗类型，北美色素沉着过度症治疗市场分为药妆、光或雷射疗法、微晶磨皮、化学换肤、冷冻疗法等。 2022年，药妆领域占据最大的市场份额。

根据病情，北美色素沉着过度障碍治疗市场分为黄褐斑、日光性雀斑、发炎后色素沉着等。黄褐斑细分市场在 2022 年占据最大的市场。

根据最终用户，北美色素沉着过度障碍治疗市场分为医院、皮肤科中心等。 2022 年，医院细分市场占据最大的市场份额。

按国家/地区划分，北美色素沉着过度障碍治疗市场分为美国、加拿大和墨西哥。 2022 年，美国在北美色素沉着过度障碍治疗市场份额中占据主导地位。

艾伯维公司（AbbVie Inc）、拜耳公司（Bayer AG）、高德玛公司（Galderma SA）、欧莱雅公司（L'OREAL SA）、路创力有限公司（Lutronic Co Ltd）、欧邦琪药妆有限责任该公司（Obagi Cosmeceuticals LLC）和维维亚製药公司（Vivier Pharma Inc）是北美色素沉着过度障碍治疗市场的一些领先公司。

Melasma, one of the most dominant hyperpigmentation conditions, is characterized by symmetrical light to dark muddy-brown macules with borders on the face, particularly the chin, upper lip, nose, forehead, and cheeks. It is prevalent among women and those with darker complexion. Malar, mandibular, and centrofacial clinical features are common in melasma. Sun exposure, hormonal variations, pregnancy, hereditary factors, cosmetics, and medicines have all been linked to the development of melasma. Various studies have estimated that the overall prevalence of melasma in the general population ranges from 1% to 50%. 55-64% of melasma cases have reported a family history of the same condition. Moreover, a greater prevalence is reported in individuals of East Asian and Hispanic origins as well as in patients with high Fitzpatrick skin phototypes (IV to VI); it is also higher in individuals living in locations that receive intense UV radiation.

Pregnancy is another common cause of melasma. This condition also impacts women taking oral contraceptives and hormones. Estrogen, progesterone, and melanocyte-stimulating hormone levels normally rise during the third trimester of pregnancy, which may be a factor. According to the National Center for Biotechnology Information (NCBI) in August 2023, melasma is more common in reproductive years, and it rarely occurs before puberty; the condition occurs in 15-50% of pregnant women, and its prevalence ranges from 1.5% to 33%, depending on the population in a different region. Therefore, an upsurge in melasma prevalence triggers the demand for hyperpigmentation treatments.

North America Hyperpigmentation Disorder Treatment Market Overview

The hyperpigmentation disorder treatment market in North America is segmented into the US, Canada, and Mexico. The US held the largest North America hyperpigmentation disorder treatment market share in 2023. According to the Skin of Color Update 2024 (a dermatology conference), the demographics of the US are evolving with the growth of ethnic and racial diversity driven by international migration of Hispanics, Asian populations, and Africans in the country, which is also likely to lead to a minority-majority shift around the year 2050 toward individuals of Fitzpatrick III, IV, V, and VI skin types. Specifically, the Hispanic population is expected to be among the fastest-growing demographic groups in the US, with estimated growth from 55 million in 2014 to 119 million in 2060. A dark skin type is more prone to hyperpigmentation disorders.

The number of aesthetic procedures in the US has increased significantly over the last 10 years. According to the International Society of Plastic Surgeons (ISAPS), the number of nonsurgical aesthetic procedures rose by 19.9% in 2021 compared to 2020 globally. Intense pulsed light (IPL) treatment is among the top 5 minimally invasive cosmetic procedures, and ~827,000 IPL procedures were performed in the US in 2020. Thus, technological advancements in noninvasive procedures are likely to further benefit the hyperpigmentation disorder treatment market in the US. In March 2023, the US Food and Drug Administration (FDA) cleared Candela Corporation's PicoWay laser to treat cafe au lait, melasma, lentigines, and Nevus of Ota. Previously, the laser system was approved for the treatment of benign pigmented lesions, acne scarring, wrinkles, and tattoo removal, among other indications.

Therefore, factors such as the growing ethnic and racial diversity, and the development of noninvasive medical aesthetic procedures such as cosmeceutics, chemical peels, cryotherapy, light, or laser therapy contribute to the hyperpigmentation disorder treatment market growth in the US.

North America Hyperpigmentation Disorder Treatment Market Revenue and Forecast to 2030 (US$ Million)

North America Hyperpigmentation Disorder Treatment Market Segmentation

The North America hyperpigmentation disorder treatment market is categorized into treatment type, condition, end user, and country.

Based on treatment type, the North America hyperpigmentation disorder treatment market is segmented into cosmeceutical, light or laser therapy, microdermabrasion, chemical peels, cryotherapy, and others. The cosmeceutical segment held the largest market share in 2022.

Based on condition, the North America hyperpigmentation disorder treatment market is segmented into melasma, solar lentigines, post-inflammatory hyperpigmentation, and others. The melasma segment held the largest market share in 2022.

Based on end user, the North America hyperpigmentation disorder treatment market is segmented into hospitals, dermatology centers, and others. The hospitals segment held the largest market share in 2022.

By country, the North America hyperpigmentation disorder treatment market is segmented into the US, Canada, and Mexico. The US dominated the North America hyperpigmentation disorder treatment market share in 2022.

AbbVie Inc, Bayer AG, Galderma SA, L'OREAL S.A., Lutronic Co Ltd, Obagi Cosmeceuticals LLC, and Vivier Pharma Inc are some of the leading companies operating in the North America hyperpigmentation disorder treatment market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Hyperpigmentation Disorder Treatment Market - Key Market Dynamics

4.1 Market Drivers
- 4.1.1 Rise in Prevalence of Melasma
- 4.1.2 Increasing Number of Hyperpigmentation Disorder Awareness Programs
4.2 Market Restraints
- 4.2.1 High Cost of Treatments
4.3 Market Opportunities
- 4.3.1 Strategic Initiatives by Market Players
4.4 Future Trends
- 4.4.1 Use of Ablative Lasers
- 4.4.2 Novel Products Based on PATH-3 Technology
4.5 Impact of Drivers and Restraints:

5. Hyperpigmentation Disorder Treatment Market - North America Analysis

5.1 North America Hyperpigmentation Disorder Treatment Market Revenue (US$ Million), 2020-2030

6. North America Hyperpigmentation Disorder Treatment Market Analysis - by Treatment Type

6.1 Cosmeceutical
- 6.1.1 Overview
- 6.1.2 Cosmeceutical: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
6.2 Light or Laser Therapy
- 6.2.1 Overview
- 6.2.2 Light or Laser Therapy: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
6.3 Microdermabrasion
- 6.3.1 Overview
- 6.3.2 Microdermabrasion: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Chemical Peels
- 6.4.1 Overview
- 6.4.2 Chemical Peels: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Cryotherapy
- 6.5.1 Overview
- 6.5.2 Cryotherapy: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Others
- 6.6.1 Overview
- 6.6.2 Others: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)

7. North America Hyperpigmentation Disorder Treatment Market Analysis - by Condition

7.1 Melasma
- 7.1.1 Overview
- 7.1.2 Melasma: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.2 Solar Lentigines
- 7.2.1 Overview
- 7.2.2 Solar Lentigines: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Post-inflammatory Hyperpigmentation
- 7.3.1 Overview
- 7.3.2 Post-inflammatory Hyperpigmentation: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Others
- 7.4.1 Overview
- 7.4.2 Others: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Hyperpigmentation Disorder Treatment Market Analysis - by End User

8.1 Hospitals
- 8.1.1 Overview
- 8.1.2 Hospitals: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.2 Dermatology Centers
- 8.2.1 Overview
- 8.2.2 Dermatology Centers: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Others
- 8.3.1 Overview
- 8.3.2 Others: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Hyperpigmentation Disorder Treatment Market - Country Analysis

9.1 North America Hyperpigmentation Disorder Treatment Market
- 9.1.1 North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast Analysis - by Country
  - 9.1.1.1 North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast Analysis - by Country
  - 9.1.1.2 US
  - 9.1.1.3 US: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.1.3.1 US: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
    - 9.1.1.3.2 US: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
    - 9.1.1.3.3 US: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
  - 9.1.1.4 Canada
  - 9.1.1.5 Canada: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.1.5.1 Canada: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
    - 9.1.1.5.2 Canada: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
    - 9.1.1.5.3 Canada: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
  - 9.1.1.6 Mexico
  - 9.1.1.7 Mexico: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
    - 9.1.1.7.1 Mexico: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
    - 9.1.1.7.2 Mexico: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
    - 9.1.1.7.3 Mexico: Hyperpigmentation Disorder Treatment Market Breakdown, by End User

10. Hyperpigmentation Disorder Treatment Market - Industry Landscape

10.1 Overview
10.2 Growth Strategies in Hyperpigmentation Disorder Treatment Market
10.3 Organic Growth Strategies
- 10.3.1 Overview
10.4 Inorganic Growth Strategies
- 10.4.1 Overview

11. Company Profiles

11.1 AbbVie Inc
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 Galderma SA
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 Obagi Cosmeceuticals LLC
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 Bayer AG
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 Lutronic Co Ltd
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 L'OREAL S.A.
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 Pierre Fabre SA
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
11.8 Vivier Pharma Inc
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Products and Services
- 11.8.4 Financial Overview
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments

12. Appendix

12.1 About The Insight Partners
12.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. North America Hyperpigmentation Disorder Treatment Market Segmentation
Table 2. North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment Type
Table 3. North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Condition
Table 4. North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
Table 5. North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Country
Table 6. Number of Laser-Based Nonsurgical Procedures Performed, 2020
Table 7. US: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment Type
Table 8. US: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Condition
Table 9. US: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
Table 10. Canada: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment Type
Table 11. Canada: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Condition
Table 12. Canada: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
Table 13. Mexico: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment Type
Table 14. Mexico: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Condition
Table 15. Mexico: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
Table 16. Recent Organic Growth Strategies in Hyperpigmentation Disorder Treatment Market
Table 17. Recent Inorganic Growth Strategies in the Hyperpigmentation Disorder Treatment Market
Table 18. Glossary of Terms, Hyperpigmentation Disorder Treatment Market

List Of Figures

Figure 1. North America Hyperpigmentation Disorder Treatment Market Segmentation, by Country
Figure 2. North America Hyperpigmentation Disorder Treatment Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. North America Hyperpigmentation Disorder Treatment Market Revenue (US$ Million), 2022-2030
Figure 5. North America Hyperpigmentation Disorder Treatment Market Share (%) - by Treatment Type (2022 and 2030)
Figure 6. Cosmeceutical: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Light or Laser Therapy: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Microdermabrasion: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Chemical Peels: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Cryotherapy: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Others: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. North America Hyperpigmentation Disorder Treatment Market Share (%) - by Condition (2022 and 2030)
Figure 13. Melasma: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Solar Lentigines: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Post-inflammatory Hyperpigmentation: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Others: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. North America Hyperpigmentation Disorder Treatment Market Share (%) - by End User (2022 and 2030)
Figure 18. Hospitals: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Dermatology Centers: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Others: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. North America Hyperpigmentation Disorder Treatment Market, By Key Country - Revenue (2022) (US$ Million)
Figure 22. North America Hyperpigmentation Disorder Treatment Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 23. US: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Canada: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Mexico: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Growth Strategies in Hyperpigmentation Disorder Treatment Market